Literature DB >> 19910050

Peptide binding to MHC class I and II proteins: new avenues from new methods.

Rakina Yaneva1, Clemens Schneeweiss, Martin Zacharias, Sebastian Springer.   

Abstract

Major histocompatibility complex (MHC) class I and II proteins have been in the focus of interest for immunologists, biochemists, cell biologists, and structural biologists for decades. With dozens of entries in the Protein Data Bank, their crystal structures are now sufficiently well understood, while their dynamic properties such as peptide binding and intracellular trafficking and their immunological (as well as non-immunological) functions are still being intensely investigated. In recent years, new methods and technologies have emerged to detect and characterize the conformational changes and intermediate states that accompany peptide binding and exchange by MHC proteins. These techniques have delivered more detailed information and allowed us to compare the molecular mechanisms of peptide selection between MHC class I and II proteins, suggesting both similarities and differences. Here, we review these recent achievements and suggest avenues for further work. Copyright 2010 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2009        PMID: 19910050     DOI: 10.1016/j.molimm.2009.10.008

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  20 in total

1.  Dipeptides catalyze rapid peptide exchange on MHC class I molecules.

Authors:  Sunil Kumar Saini; Heiko Schuster; Venkat Raman Ramnarayan; Hans-Georg Rammensee; Stefan Stevanović; Sebastian Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

2.  An N-end rule pathway that recognizes proline and destroys gluconeogenic enzymes.

Authors:  Shun-Jia Chen; Xia Wu; Brandon Wadas; Jang-Hyun Oh; Alexander Varshavsky
Journal:  Science       Date:  2017-01-27       Impact factor: 47.728

3.  Can self-inhibitory peptides be derived from the interfaces of globular protein-protein interactions?

Authors:  Nir London; Barak Raveh; Dana Movshovitz-Attias; Ora Schueler-Furman
Journal:  Proteins       Date:  2010-11-15

4.  An integrated approach to epitope analysis II: A system for proteomic-scale prediction of immunological characteristics.

Authors:  Robert D Bremel; E Jane Homan
Journal:  Immunome Res       Date:  2010-11-02

5.  T-cell epitope prediction and immune complex simulation using molecular dynamics: state of the art and persisting challenges.

Authors:  Matthew N Davies; Darren R Flower; Kanchan Phadwal; Isabel K Macdonald; Peter V Coveney; Shunzhou Wan
Journal:  Immunome Res       Date:  2010-11-03

6.  Reactomes of porcine alveolar macrophages infected with porcine reproductive and respiratory syndrome virus.

Authors:  Zhihua Jiang; Xiang Zhou; Jennifer J Michal; Xiao-Lin Wu; Lifan Zhang; Ming Zhang; Bo Ding; Bang Liu; Valipuram S Manoranjan; John D Neill; Gregory P Harhay; Marcus E Kehrli; Laura C Miller
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

7.  The Carboxy Terminus of the Ligand Peptide Determines the Stability of the MHC Class I Molecule H-2Kb: A Combined Molecular Dynamics and Experimental Study.

Authors:  Esam Tolba Abualrous; Sunil Kumar Saini; Venkat Raman Ramnarayan; Florin Tudor Ilca; Martin Zacharias; Sebastian Springer
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

8.  Impact of Structural Observables From Simulations to Predict the Effect of Single-Point Mutations in MHC Class II Peptide Binders.

Authors:  Rodrigo Ochoa; Roman A Laskowski; Janet M Thornton; Pilar Cossio
Journal:  Front Mol Biosci       Date:  2021-03-30

9.  Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study.

Authors:  Amit Kumar; Eleonora Cocco; Luigi Atzori; Maria Giovanna Marrosu; Enrico Pieroni
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

10.  Children who develop type 1 diabetes early in life show low levels of carnitine and amino acids at birth: does this finding shed light on the etiopathogenesis of the disease?

Authors:  G la Marca; S Malvagia; S Toni; B Piccini; V Di Ciommo; G F Bottazzo
Journal:  Nutr Diabetes       Date:  2013-10-28       Impact factor: 5.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.